12 Nov
12Nov

As US mulls starting vaccinations in December and Pfizer looks at several opportunities to make its COVID-19 vaccine available in India, several volunteers who participated in the US trials have started reporting side effects from the shot.

One of the volunteers of the trial, Texas lobbyist Glenn Deshields compared side effects of the shot as being similar to "a severe hangover" whereas another one, 45-year old Carrie said that she went through fever, body aches and headache after the second shot.

 More than 43,500 volunteers across 6 countries have participated in the phase-3 trials run jointly by the New York-headquartered pharma giant and the German pharma behemoth BioNTech. 

Source : Business Today

Comments
* The email will not be published on the website.